Occurrence of diverse mutations in isoniazid-and rifampicin-resistant mycobacterium tuberculosis isolates from autochthonous and immigrant populations of Saudi Arabia

Microbial Drug Resistance

Volumn 20, Issue 6, 2014, Pages 623-631

  Varghese, Bright ^a   Shoukri, Mohammed ^a   Memish, Ziad ^b   Abuljadayel, Naila ^b   Alhakeem, Raafat ^b   Alrabiah, Fahad ^a   Al Hajoj, Sahal ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b MINISTRY OF HEALTH   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN; ANTIINFECTIVE AGENT; BACTERIAL DNA; BACTERIAL PROTEIN; CODON; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CODON; GENE MUTATION; IMMIGRANT; MUTATIONAL ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHYLOGENY; SAUDI ARABIA; VARIABLE NUMBER OF TANDEM REPEAT; DRUG EFFECTS; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MIGRANT; MULTIDRUG RESISTANT TUBERCULOSIS; MUTATION;

MYCOBACTERIUM TUBERCULOSIS;

ANTI-BACTERIAL AGENTS; ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; CODON; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; EMIGRANTS AND IMMIGRANTS; HUMANS; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; RIFAMPIN; SAUDI ARABIA; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84915796662     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2014.0065     Document Type: Article

References (30)

1. Abal, A.T., S. Ahmad, and E. Mokaddas. 2002. Variations in the occurrence of the S315T mutation within the katG gene in isoniazid-resistant clinical Mycobacterium tuberculosis isolates from Kuwait. Microb. Drug Resist. 8:99-105.
2. Afanas'ev, M.V., L.N. Ikryannikova, E.N. Il'ina, S.V. Sidorenko, A.V. Kuz'min, E.E. Larionova, T.G. Smirnova, L.N. Chernousova, E.Y. Kamaev, S.N. Skorniakov, et al. 2007. Molecular characteristics of rifampicin-and isoniazid-resistant Mycobacterium tuberculosis isolates from the Russian Federation. J. Antimicrob. Chemother. 59:1057-1064.
3. Ahmad, S., N.M. Al-Mutairi, and E. Mokaddas. 2012. Variations in the occurrence of specific rpoB mutations in rifampicin-resistant Mycobacterium tuberculosis isolates from patients of different ethnic groups in Kuwait. Indian J. Med. Res. 135:756-762.
4. Al-Hajoj, S., B. Varghese, M.M. Shoukri, R. Al-Omari, M. Al-Herbwai, F. Alrabiah, A.A. Alrajhi, N. Abuljadayel, S. Al-Thawadi, A. Zumla, et al. 2013. Epidemiology of antituberculosis drug resistance in Saudi Arabia: findings of the first national survey. Antimicrob. Agents Chemother. 57:2161-2166.
5. Allix-Beguec, C., D. Harmsen, T. Weniger, P. Supply, and S. Niemann. 2008. Evaluation and strategy for use of MIRU-VNTRplus, a multifunctional database for online analysis of genotyping data and phylogenetic identification of Mycobacterium tuberculosis complex isolates. J. Clin. Microbiol. 46:2692-2699.
6. Bahrmand, A.R., L.P. Titov, A.H. Tasbiti, S. Yari, and E.A. Graviss. 2009. High-level rifampin resistance correlates with multiple mutations in the rpoB gene of pulmonary tuberculosis isolates from the Afghanistan border of Iran. J. Clin. Microbiol. 47:2744-2750.
7. Bicmen, C., A.T. Gunduz, M. Coskun, G. Senol, N. Ozkutuk, A.K. Cirak, and R. Ozacar. 2008. Molecular identification and characterization of rifampicin-resistant Mycobacterium tuberculosis isolates by line probe assay: an approach for rapid diagnosis of multidrug-resistant tuberculosis. Lett. Appl. Microbiol. 47:214-220.
8. Gagneux, S., and P.M. Small. 2007. Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development. Lancet Iinfect. Dis. 7:328-337.
9. Herrera, L., A. Valverde, P. Saiz, J.A. Saez-Nieto, J.L. Portero, and M.S. Jimenez. 2004. Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis clinical strains isolated in the Philippines. Int. J. Antimicrob. Agents 23:572-576.
10. Hoshide, M., L. Qian, C. Rodrigues, R. Warren, T. Victor, H.B. Evasco, 2nd, T. Tupasi, V. Crudu, and J.T. Douglas. 2013. Geographical differences associated with SNPs in nine gene targets among resistant clinical isolates of Mycobacterium tuberculosis. J. Clin. Microbiol. 51: 3913.
11. Huang, H., Q. Jin, Y. Ma, X. Chen, and Y. Zhuang. 2002. Characterization of rpoB mutations in rifampicinresistant Mycobacterium tuberculosis isolated in China. Tuberculosis 82:79-83.
12. Imperiale, B.R., M.J. Zumarraga, A.B. Di Giulio, A.A. Cataldi, and N.S. Morcillo. 2013. Molecular and phenotypic characterisation of Mycobacterium tuberculosis resistant to anti-tuberculosis drugs. Int. J. Tuberc. Lung Dis. 17:1088-1093.
13. Khadka, D.K., B. Eampokalap, J. Panitchakorn, P. Ramasoota, and S. Khusmith. 2007. Multiple mutations in katG and inhA identified in Thai isoniazid-resistant Mycobacterium tuberculosis isolates. Southeast Asian J. Trop. Med. Public Health 38:376-382.
14. Kozhamkulov, U., A. Akhmetova, S. Rakhimova, E. Belova, A. Alenova, V. Bismilda, L. Chingissova, S. Ismailov, E. Ramanculov, and K. Momynaliev. 2011. Molecular characterization of rifampicin-and isoniazidresistant Mycobacterium tuberculosis strains isolated in Kazakhstan. Jpn. J. Infect. Dis. 64:253-255.
15. Laurenzo, D., and S.A Mousa. 2011. Mechanisms of drug resistance in Mycobacterium tuberculosis and current status of rapid molecular diagnostic testing. Acta Trop. 119:5-10.
16. Madania, A., M. Habous, H. Zarzour, I. Ghoury, and B. Hebbo. 2012. Characterization of mutations causing rifampicin and isoniazid resistance of Mycobacterium tuberculosis in Syria. Pol. J. Microbiol. 61:23-32.
17. Maurya, A.K., A.K. Singh, S. Kant, J. Umrao, M. Kumar, R.A. Kushwaha, V.L. Nag, and T.N. Dhole. 2013. Use of GenoType(R) MTBDRplus assay to assess drug resistance and mutation patterns of multidrug-resistant tuberculosis isolates in northern India. Indian J. Med. Microbiol. 31:230-236.
18. Minh, N.N., N. Van Bac, N.T. Son, V.T. Lien, C.H. Ha, N.H. Cuong, C.T. Mai, and T.H. Le. 2012. Molecular characteristics of rifampin-and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Vietnam. J. Clin. Microbiol. 50:598-601.
19. Nathanson, E., P. Nunn., M. Uplekar, K. Floyd, E. Jaramillo, K. Lonnroth, D. Weil, and M. Raviglione. 2010. MDR tuberculosis-critical steps for prevention and control. N. Engl. J. Med. 363:1050-1058.
20. Organization World Health. 2010. Treatment of Tuberculosis Guidelines. WHO, Geneva, Switzerland.
21. Organization World Health. 2013. Global Tuberculosis Report, WHO, Geneva, 2013. Available at www.who.int./tb/publications/global-reports. (Online.).
22. Poudel, A., B. Maharjan, C. Nakajima, Y. Fukushima, B.D. Pandey, A. Beneke, and Y. Suzuki. 2013. Characterization of extensively drug-resistant Mycobacterium tuberculosis in Nepal. Tuberculosis 93:84-88.
23. Rahim, Z., C. Nakajima, R. Raqib, K. Zaman, H.P. Endtz, A.G. van der Zanden, and Y. Suzuki. 2012. Molecular mechanism of rifampicin and isoniazid resistance in Mycobacterium tuberculosis from Bangladesh. Tuberculosis 92:529-534.
24. Somoskovi, A., Q. Song, J. Mester, C. Tanner, Y.M. Hale, L.M. Parsons, and M. Salfinger. 2003. Use of molecular methods to identify the Mycobacterium tuberculosis complex (MTBC) and other mycobacterial species and to detect rifampin resistance in MTBC isolates following growth detection with the BACTEC MGIT 960 system. J. Clin. Microbiol. 41:2822-2826.
25. Tang, K., H. Sun, Y. Zhao, J. Guo, C. Zhang, Q. Feng, Y. He, M. Luo, Y. Li, and Q. Sun. 2013. Characterization of rifampin-resistant isolates of Mycobacterium tuberculosis from Sichuan in China. Tuberculosis 93:89-95.
26. Varghese, B., R. al-Omari, C. Grimshaw, and S. Al-Hajoj. 2013. Endogenous reactivation followed by exogenous re-infection with drug resistant strains, a new challenge for tuberculosis control in Saudi Arabia. Tuberculosis 93:246-249.
27. Varghese, B., A. Hillemann, D.R. Wijayanti, M. Shoukri, F. Al-rabiah, R. Al-Omari, and S. Al-Hajoj. 2012. New insight into the molecular characterization of isoniazid and rifampicin resistant Mycobacterium tuberculosis strains from Saudi Arabia. Infect. Genet. Evol. 12: 549-556.
28. Varghese, B., P. Supply, C. Allix-Beguec, M. Shoukri, R. Al-Omari, M. Herbawi, and S. Al-Hajoj. 2013. Admixed phylogenetic distribution of drug resistant Mycobacterium tuberculosis in Saudi Arabia. PLoS One 8:e55598.
29. Varghese, B., P. Supply, M. Shoukri, C. Allix-Beguec, Z. Memish, N. Abuljadayel, R. Al-Hakeem, F. AlRabiah, and S. Al-Hajoj. 2013. Tuberculosis transmission among immigrants and autochthonous populations of the eastern province of Saudi Arabia. PLoS One 8:e77635.
30. Yadav, R.N., B.K. Singh, S.K. Sharma, R. Sharma, M. Soneja, V. Sreenivas, V.P. Myneedu, M. Hanif, A. Kumar, K.S. Sachdeva, et al. 2013. Comparative evaluation of genotype MTBDRplus line probe assay with solid culture method in early diagnosis of multidrug resistant tuberculosis (MDR-TB) at a Tertiary Care Centre in India. PLoS One 8:e72036.